Article · 10 Jun 2026
Conference abstract
Anti-inflammation and neuroprotective drugs benefit the treatment of bipolar II disorder patients
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Low dose memantine might possess anti-inflammatory and neuroprotective effects mechanistically remote from the NMDA receptor. We investigated whether using valproic acid (VPA) add-on memantine (5 mg/day) to treat bipolar II disorder (BP-II) is more effective than using VPA alone. In this randomized, double-blind, controlled 12 week study, BP-II patients were randomly assigned to a group: VPA+Memantine or VPA+Placebo (Pbo). The Hamilton Depression Rating Scale (HDRS) and Young Mania Rating Scale (YMRS) were used to evaluate clinical response, alone with plasma levels of tumor necrosis factor (TNF-Ã?±), interleukin 6 (IL-6), IL-8, and IL-1and metabolic profiles during week 0, 1, 2, 4, 8 and 12.After 12 weeks, there was a significant increase of high-density lipoprotein cholesterol (HDL-C) (p<0.009) in the memantine group compared with the Pbo group. The TNF-Ã?± were significantly decreased in the memantine group than in the Pbo group (P=0.013).The changes in HDRS score were significantly associated with changes in IL-6 (P=0.012) and IL-1(P=0.005) levels; changes in YMRS score associated with changes with TNF-Ã?±(P=0.005) level changes.The association between BDNF Val66Met polymorphism with treatment response was evaluated. After stratified by BDNF Val66Met genotypes, significantly greater decreases in HDRS scores were found in the VPA+memantine group in patients with the Val/Met genotype (p=0.004). We conclude that memantine might benefit treatment of BP-II via decreasing cytokines and increasing HDL-C. The BDNF Val66Met polymorphism influences responses to add-on memantine by decreasing depressive symptoms in BP-II.
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Brain Disorders & Therapy.
Article · 10 Jun 2026
Brain Network Dysfunction: How Altered Neural Communication Affects Health
Article · 10 Jun 2026
Mitochondrial Encephalopathy: Understanding Energy Failure in the Nervous System
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBrain Disorders & Therapy
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Ru-B”
- BylineArticles whose byline prints “Lu”
- BylineArticles whose byline prints “Sheng-Yu Lee”
- BylineArticles whose byline prints “Shiou-Lan Chen”
- BylineArticles whose byline prints “Yun-Hsuan Chang”
